Multicenter phase II study of SIR-sphere plus sorafenib as first-line treatment in patients with nonresectable hepatocellular carcinoma: The Asia-Pacific Hepatocellular Carcinoma Trials Group Protocol 05 (AHCC05).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 4072-4072 ◽  
Author(s):  
P. K. Chow ◽  
D. Poon ◽  
K. M. Win ◽  
H. Singh ◽  
H. S. Han ◽  
...  
2008 ◽  
Vol 64 (2) ◽  
pp. 317-325 ◽  
Author(s):  
Kyung Hee Lee ◽  
Min Kyoung Kim ◽  
Yeol Hong Kim ◽  
Baek Yeol Ryoo ◽  
Ho Yeong Lim ◽  
...  

1997 ◽  
Vol 33 ◽  
pp. S236 ◽  
Author(s):  
N. Androulakis ◽  
C. Kourousis ◽  
S. Kakolyris ◽  
A.M. Dimopoulos ◽  
E. Papadakis ◽  
...  

1998 ◽  
Vol 9 (3) ◽  
pp. 331-334 ◽  
Author(s):  
V. Georgoulias ◽  
N. Androulakis ◽  
A.M. Dimopoulos ◽  
C. Kourousis ◽  
S. Kakolyris ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document